Mirae Asset Global Investments Co., Ltd. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$495,633
-12.9%
63,788
+8.5%
0.00%0.0%
Q2 2023$568,952
-12.1%
58,776
-0.5%
0.00%
-50.0%
Q1 2023$647,286
+153.4%
59,059
-0.1%
0.00%
+100.0%
Q4 2022$255,476
-42.6%
59,138
+0.1%
0.00%0.0%
Q3 2022$445,000
+5.5%
59,083
+40.7%
0.00%0.0%
Q2 2022$422,00041,9870.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders